Interview with Worwick Anderson, NHMRC,
Would you begin by outlining the key milestones & achievements of the NHMRC in the past four years? The first point is the development of our initiatives on an international…
Address: Level 1, 16 Marcus Clarke Street, Canberra,Australia
Tel: +61 2 6217 9000
The NHMRC is Australia’s NIH equivalent, being the big government funding body for health and medical research. We have always had in our portfolio a full range of health and medical research. Some funding bodies like the UKMRC are more biomedical, but the NHMRC has always been concerned with public health and health services research, so it’s a very broad portfolio. The NHMRC is more than a funding body, and strives to improve the lives of all Australians. For example, the organization publishes evidence-based guidelines for clinical practice and public health. An example of the latter is the current work being completed in finalizing safe alcohol-drinking guidelines, around which there is some controversy as we speak, because the message from science and what the public would like to believe do not always align.
The NHMRC also manages research and clinical ethics systems for Australia, publishing guidelines in this regard. Overall, it’s a fantastic organization of great importance to the health and wealth of the country. The NHMRC was a part of the Department of Health until July of 2006, when, coinciding with my arrival, we became an independent government body within the health portfolio, reporting directly to the Minister, which gives us all sorts of opportunities. Other aspects of the NHMRC portfolio include acting as the body under the Australian parliament act around stem cells, to issue licensing for cloning and embryo experimentation.
Would you begin by outlining the key milestones & achievements of the NHMRC in the past four years? The first point is the development of our initiatives on an international…
Your distinguished career in health research leadership and management has seen you through a variety of prestigious positions, not to mention the Order of Australia. Most recently you were appointed…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then…
“Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when Focus Reports met you first in 2008.…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then…
Senior Partner Dr Sree Haran has also participated in this interview. TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would…
The company underwent some landmark changes under your leadership, changing the balance between different pillars of the business – retail, wholesale product delivery, marketing programs. Would you begin by outlining…
After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and…
Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have diabetes and about half of those are…
Would you begin by outlining the key milestones & achievements of the NHMRC in the past four years? The first point is the development of our initiatives on an international…
Would you please introduce The Pharmacy Guild to our readers, giving an insight in its function and its membership? We are the premium body representing community pharmacies in Australia, about…
Earlier this year the company set a crucial step in its internationalization strategy with the acquisition of Ascent. Would you outline the significance of the acquisition within Watson’s global expansion…
We last met you in 2008 as Chair of the Pharmaceuticals Industry Council (PIC), which set itself the goal of doubling the levels of exports, R&D investment, manufacturing, value-added activities,…
Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper? Issues faced by the pharmaceutical industry are not unlike…
See our Cookie Privacy Policy Here
